It has been reported that regions with a high prevalence of the PNPLA3 gene mutation, which is a disease susceptibility gene for NAFLD, have a higher number of patients with non-obese NAFLD [5]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.